EP3078743
MÓTEFNI VIÐ XA-ÞÁTTARHEMLUM OG AÐFERÐIR VIÐ NOTKUN ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.9.2008EP published:
24.6.2020EP application number:
16167534.3
EP translation filed:
10.8.2020Grant published:
15.9.2020EPO information:
European Patent Register
Max expiry date:
25.9.2028Expiry date:
25.9.2026Next due date:
30.9.2026
Title:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
Timeline
Today
26.9.2008EP application
24.6.2020EP Publication
10.8.2020Translation submitted
15.9.2020Registration published
25.9.2026Expires
Owner
Name:
Alexion Pharmaceuticals, Inc.Address:
121 Seaport Boulevard, 02210, Boston, Massachusetts, US
Inventor
Name:
LU, GenminAddress:
Burlingame, CA 94010, US
Name:
PHILLIPS, David R.Address:
San Mateo, CA 94402, US
Name:
ANDRE, PatrickAddress:
Short Hills, NJ 07078, US
Name:
SINHA, UmaAddress:
San Francisco, CA 94127, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
976343 PDate:
28.9.2007Country:
US
Number:
90574 PDate:
20.8.2008Country:
US
Supplementary protection
SPC number:
SPC325
Classification
Categories:
C12N 9/64, A61P 7/04, A61K 38/48
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 11.9.2020
Expires: 25.9.2021
Payer: Tego ehf.
Number: 14
Paid: 31.8.2021
Expires: 25.9.2022
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 31.8.2022
Expires: 25.9.2023
Payer: Patice ehf.
Number: 16
Paid: 19.9.2023
Expires: 25.9.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 17.9.2024
Expires: 25.9.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 15.9.2025
Expires: 25.9.2026
Payer: Árnason Faktor ehf.